FranceschiniMBoffaAPignottiEAndrioloLZaffagniniSFilardoG. The minimal clinically important difference changes greatly based on the different calculation methods. Am J Sports Med. 2023;51(4):1067-1073.
2.
Public Workshop on Patient-Focused Drug Development: Guidance 4—Incorporating Clinical Outcome Assessments into Endpoints for Regulatory Decision Making. FDA; 2019. Accessed July 30, 2023. https://www.fda.gov/media/132505/download
3.
TerweeCBPeipertJDChapmanR, et al. Minimal important change (MIC): a conceptual clarification and systematic review of MIC estimates of PROMIS measures. Qual Life Res. 2021;30(10):2729-2754.
